ID   LUTC-14
AC   CVCL_RP49
SY   Lund University Thyroid Carcinoma-14
DR   Wikidata; Q54903281
RX   PubMed=25212604;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25212604
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 8,13
ST   D18S51: 12,15
ST   D19S433: 13.2,16
ST   D21S11: 28
ST   D2S1338: 17,23
ST   D3S1358: 18
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 12,15
ST   FGA: 22
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
RX   PubMed=25212604; DOI=10.1158/1078-0432.CCR-14-0291;
RA   Wennerberg, Erik
RA   Pfefferle, Aline
RA   Ekblad, Lars
RA   Yoshimoto, Yuya
RA   Kremer, Veronika
RA   Kaminskyy, Vitaliy O.
RA   Juhlin, Carl Christofer
RA   Hoog, Anders
RA   Bodin, Inger
RA   Svjatoha, Vitalijs
RA   Larsson, Catharina
RA   Zedenius, Jan
RA   Wennerberg, Johan
RA   Lundqvist, Andreas
RT   "Human anaplastic thyroid carcinoma cells are sensitive to NK
RT   cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.";
RL   Clin. Cancer Res. 20:5733-5744(2014).
//